Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Manuel Busto Iglesias"'
Autor:
Carmen Antía Rodríguez-Fernández, Manuel Busto Iglesias, Begoña de Domingo, Kelly Conde-Pérez, Juan A. Vallejo, Lorena Rodríguez-Martínez, Miguel González-Barcia, Victor Llorenç, Cristina Mondelo-Garcia, Margarita Poza, Anxo Fernández-Ferreiro
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 13, p 7020 (2022)
In the last decades, personalized medicine has been increasing its presence in different fields of medicine, including ophthalmology. A new factor that can help us direct medicine towards the challenge of personalized treatments is the microbiome. Th
Externí odkaz:
https://doaj.org/article/54d10d814370422283532d15286ce968
Autor:
Manuel Busto-Iglesias, Lorena Rodríguez-Martínez, Carmen Antía Rodríguez-Fernández, Jaime González-López, Miguel González-Barcia, Begoña de Domingo, Luis Rodríguez-Rodríguez, Anxo Fernández-Ferreiro, Cristina Mondelo-García
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 766 (2023)
Biological drugs, especially those targeting anti-tumour necrosis factor α (TNFα) molecule, have revolutionized the treatment of patients with non-infectious uveitis (NIU), a sight-threatening condition characterized by ocular inflammation that can
Externí odkaz:
https://doaj.org/article/8c4d486997494c368dbb809f366f0433
Autor:
Ana, Castro-Balado, Iria, Varela-Rey, Enrique José, Bandín-Vilar, Manuel, Busto-Iglesias, Laura, García-Quintanilla, Cristina, Mondelo-García, Anxo, Fernández-Ferreiro
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 44(7)
The health crisis resulting from the rapid spread of SARS-CoV-2 worlwide, added to the low evidence of currently used treatments has led to the development of a large number of clinical trials (CT) and observational studies. Likewise, important measu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1bf37f0f2c3f0847d6e454734f4ac83e
https://pubmed.ncbi.nlm.nih.gov/32533675
https://pubmed.ncbi.nlm.nih.gov/32533675
Autor:
Laura García-Quintanilla, María Carmen Del Río-Garma, Ana Rodríguez-Bernaldo de Quirós, Carlos Rábade-Castedo, Rocío Trastoy-Pena, Cristina Mondelo-García, Ana Castro-Balado, Jordi Llop, Iria Varela-Rey, Letricia Barbosa-Pereira, Rossana Passannante, Enrique José Bandín-Vilar, Luis Valdés-Cuadrado, Ignacio Novo-Veleiro, Pablo Aguiar, Néstor Vázquez-Agra, Raquel Sendón-García, Anxo Fernández-Ferreiro, Manuel Busto-Iglesias, Carlos Crespo-Diz, Francisco J. Otero-Espinar, José Ramón Lago-Quinteiro, Gema Barbeito-Castiñeiras, Irene Zarra-Ferro, Miguel González-Barcia, María Luisa Pérez del Molino-Bernal, José Ramón Antúnez-López, Olga Delgado-Sánchez, Antonio Pose-Reino, David Rey-Bretal
Publikováno v:
Pharmaceutics, Vol 13, Iss 342, p 342 (2021)
Pharmaceutics
Volume 13
Issue 3
Pharmaceutics
Volume 13
Issue 3
Inhaled administration of ethanol in the early stages of COVID-19 would favor its location on the initial replication sites, being able to reduce the progression of the disease and improving its prognosis. Before evaluating the efficacy and safety of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4cdeca7705a5f32e8bd7422980e9db6
https://doi.org/10.3390/pharmaceutics13030342
https://doi.org/10.3390/pharmaceutics13030342
Autor:
Ana Castro-Balado, Cristina Mondelo-García, Letricia Barbosa-Pereira, Iria Varela-Rey, Ignacio Novo-Veleiro, Néstor Vázquez-Agra, José Ramón Antúnez-López, Enrique José Bandín-Vilar, Raquel Sendón-García, Manuel Busto-Iglesias, Ana Rodríguez-Bernaldo de Quirós, Laura García-Quintanilla, Miguel González-Barcia, Irene Zarra-Ferro, Francisco J. Otero-Espinar, David Rey-Bretal, José Ramón Lago-Quinteiro, Luis Valdés-Cuadrado, Carlos Rábade-Castedo, María Carmen del Río-Garma, Carlos Crespo-Diz, Olga Delgado-Sánchez, Pablo Aguiar, Gema Barbeito-Castiñeiras, María Luisa Pérez del Molino-Bernal, Rocío Trastoy-Pena, Rossana Passannante, Jordi Llop, Antonio Pose-Reino, Anxo Fernández-Ferreiro
Publikováno v:
Pharmaceutics, Vol 13, Iss 3, p 342 (2021)
Inhaled administration of ethanol in the early stages of COVID-19 would favor its location on the initial replication sites, being able to reduce the progression of the disease and improving its prognosis. Before evaluating the efficacy and safety of
Externí odkaz:
https://doaj.org/article/7d1e49fcc0bb49219894ecba2adc497f